Lv6
1670 积分 2023-02-14 加入
路在脚下
2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party
1个月前
已完结
Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: the GIMEMA LAL2317 phase 2 study
3个月前
已完结
Next-generation sequencing-based MRD in adults with ALL undergoing hematopoietic cell transplantation
3个月前
已完结
Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia
3个月前
已完结
Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts
3个月前
已完结
High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing
3个月前
已完结
A guide to systems-level immunomics
3个月前
已完结
Current State of Evidence on Definitions and Management of High-Risk Multiple Myeloma
3个月前
已完结
皖公网安备34019202002308
